Contact Us
Drug Search Results
More Filters [+]

Melitracen

Alternative Names: melitracen
Latest Update: 2024-04-23
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: SNR Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Bangladesh | Belgium | Bulgaria | Dominican Republic | Hong Kong | India | Italy | Jordan | Lebanon | Malta | Pakistan | Singapore | Switzerland | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: Lundbeck
Company Location: DENMARK G7 00000
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Melitracen

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Psychotic Disorders

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CTR20221656

N/A

Completed

Depressive Disorder|Neurasthenia

2022-08-08

ChiCTR1800016438

N/A

Not yet recruiting

Colitis, Ulcerative

2020-06-30

M2017013

P4

Completed

Psychotic Disorders

2020-01-31

17686A

P1

Completed

Healthy Volunteers

2018-06-28

28%

Recent News Events

Date

Type

Title

04/23/2024

PubMed

 Trends and prescribing patterns of antimigraine medicines in nine major cities in China from 2018 to 2022: a retrospective prescription analysis.

04/03/2024

PubMed

 Chinese herbal medicines for the treatment of depression: a systematic review and network meta-analysis.

03/15/2024

PubMed

 Beyond the counter: Navigating the landscape of Deanxit® dispensing - Insights from Jordanian community pharmacies.

09/14/2023

News Article

 Melitracen Market Key Facts and Forecast Predictions Presented During 2023 to 2031

08/24/2023

News Article

 China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions